| Drug Name: | Dimethyl sulfoxide (67-68-5) |
|---|---|
| PubChem ID: | 679 |
| SMILES: | CS(=O)C |
| InchiKey: | IAZDPXIOMUYVGZ-UHFFFAOYSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 78.136 |
| LogP | : | -0.0053 |
| Ring Count | : | 0 |
| Hydrogen Bond Acceptor Count | : | 1 |
| Hydrogen Bond Donor Count | : | 0 |
| Total Polar Surface Area | : | 17.07 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Sulindac (38194-50-2) | Neuropathy | Additive | Not Known | Peripheral neuropathy after concomitant dimethyl sulfoxide use and sulindac therapy |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|---|
| Chemical Cystitis | ADReCS |
| Discomfort | ADReCS |
| Dysgeusia | ADReCS |